Collectively, these findings indicate that LIMA1 functions as a downstream effector of the LRP5/Wnt signaling axis in mediating the anti-tumor actions of LRP5-overexpressing osteocyte-derived CM, and that its knockdown substantially attenuates these inhibitory effects. This evidence concerns the gene LRP5 and neoplasm.